Your browser does not fully support modern features. Please upgrade for a smoother experience.
Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic. For video creation, please contact our Academic Video Service.
Version Summary Created by Modification Content Size Created at Operation
1 handwiki Vivi Li -- 1449 2022-11-01 01:45:39

Video Upload Options

We provide professional Academic Video Service to translate complex research into visually appealing presentations. Would you like to try it?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
HandWiki. Epoetin Alfa. Encyclopedia. Available online: https://encyclopedia.pub/entry/32208 (accessed on 26 September 2026).
HandWiki. Epoetin Alfa. Encyclopedia. Available at: https://encyclopedia.pub/entry/32208. Accessed September 26, 2026.
HandWiki. "Epoetin Alfa" Encyclopedia, https://encyclopedia.pub/entry/32208 (accessed September 26, 2026).
HandWiki. (2022, November 01). Epoetin Alfa. In Encyclopedia. https://encyclopedia.pub/entry/32208
HandWiki. "Epoetin Alfa." Encyclopedia. Web. 01 November, 2022.
Epoetin Alfa
Edit

Epoetin alfa is a human erythropoietin produced in cell culture using recombinant DNA technology. Authorised by the European Medicines Agency on 28 August 2007, it stimulates erythropoiesis (increasing red blood cell levels) and is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy. Epoetin is manufactured and marketed by Amgen under the brand name Epogen. Johnson & Johnson subsidiary Janssen Biotech (formerly Ortho Biotech Products, LP), sells the same drug under the name Procrit, pursuant to a product license agreement. The average cost per patient in the U.S. was $8,447 in 2009. Darbepoetin alfa (rINN) /dɑːrbəˈpɔɪtɪn/ is a glycosylation analog of erythropoietin containing two additional N-linked carbohydrate chains, also manufactured and marketed by Amgen, with a brand name of Aranesp. The Food and Drug Administration (FDA) warnings and safety precautions for Procrit, Epogen and Aranesp are identical. For several years, epoetin alfa has accounted for the single greatest drug expenditure paid by the U.S. Medicare system; in 2010, the program paid $2 billion for the drug. Raising hemoglobin levels has been found in some studies to be associated with higher risks of thrombotic events, strokes and death. It is on the World Health Organization's List of Essential Medicines.

glycosylation red blood cell hemoglobin levels

References

  1. "A randomized controlled study of iron supplementation in patients treated with erythropoietin". Kidney International 50 (5): 1694–9. November 1996. doi:10.1038/ki.1996.487. PMID 8914038.  https://dx.doi.org/10.1038%2Fki.1996.487
  2. "Efficacy and safety of epoetin alfa in critically ill patients". The New England Journal of Medicine 357 (10): 965–76. September 2007. doi:10.1056/NEJMoa071533. PMID 17804841.  https://dx.doi.org/10.1056%2FNEJMoa071533
  3. "Erythropoietin: a candidate compound for neuroprotection in schizophrenia". Molecular Psychiatry 9 (1): 42–54. January 2004. doi:10.1038/sj.mp.4001442. PMID 14581931.  https://dx.doi.org/10.1038%2Fsj.mp.4001442
  4. "Can erythropoietin be used to prevent brain damage in cerebral malaria?". Trends in Parasitology 25 (1): 30–6. January 2009. doi:10.1016/j.pt.2008.10.002. PMID 19008152.  https://dx.doi.org/10.1016%2Fj.pt.2008.10.002
  5. "Plasmodium berghei ANKA: erythropoietin activates neural stem cells in an experimental cerebral malaria model". Experimental Parasitology 127 (2): 500–5. February 2011. doi:10.1016/j.exppara.2010.09.010. PMID 21044627.  https://dx.doi.org/10.1016%2Fj.exppara.2010.09.010
  6. "Kidney drug could save children from malaria brain damage". The Guardian (London). 17 February 2008. https://www.theguardian.com/science/2008/feb/17/medicalresearch.health1. 
  7. "Passage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa". European Journal of Pharmacology 505 (1–3): 93–101. November 2004. doi:10.1016/j.ejphar.2004.10.035. PMID 15556141.  https://dx.doi.org/10.1016%2Fj.ejphar.2004.10.035
  8. "The effect of erythropoietin on cognition in affective disorders - Associations with baseline deficits and change in subjective cognitive complaints". European Neuropsychopharmacology 26 (8): 1264–1273. August 2016. doi:10.1016/j.euroneuro.2016.05.009. PMID 27349944.  https://dx.doi.org/10.1016%2Fj.euroneuro.2016.05.009
  9. "Early erythropoiesis-stimulating agents in preterm or low birth weight infants". The Cochrane Database of Systematic Reviews 11: CD004863. November 2017. doi:10.1002/14651858.CD004863.pub5. PMID 29145693.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=6486170
  10. "Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants". The Cochrane Database of Systematic Reviews 2: CD004865. February 2020. doi:10.1002/14651858.CD004865.pub4. PMID 32048729.  http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=7014632
  11. R. Baselt, Disposition of Toxic Drugs and Chemicals in Man, 8th edition, Biomedical Publications, Foster City, CA, 2008, pp. 547-549.
  12. "Normalization of hemoglobin level in patients with chronic kidney disease and anemia". The New England Journal of Medicine 355 (20): 2071–84. November 2006. doi:10.1056/NEJMoa062276. PMID 17108342.  https://dx.doi.org/10.1056%2FNEJMoa062276
  13. "FDA Public Health Advisory: Erythropoiesis-Stimulating Agents (ESAs): Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp)". https://www.fda.gov/cder/drug/advisory/RHE2007.htm. 
  14. "Information for Healthcare Professionals: Erythropoiesis Stimulating Agents (ESA)". https://www.fda.gov/cder/drug/InfoSheets/HCP/RHE2007HCP.htm. 
  15. "Erythropoiesis Stimulating Agents: Aranesp (darbepoetin alfa), Epogen (epoetin alfa), and Procrit (epoetin alfa)". MedWatch - 2007 Safety Information Alerts. U.S. Food and Drug Administration. 3 January 2008. https://www.fda.gov/medwatch/safety/2007/safety07.htm#ESA2. 
  16. "Procrit (Epoetin alfa) for injection". U.S. Food and Drug Administration. 11 August 2007. https://www.fda.gov/cder/foi/label/2007/103234s5158lbl.pdf. 
  17. "Aranesp (darbepoetin alfa) for Injection". U.S. Food and Drug Administration. 8 November 2007. https://www.fda.gov/cder/foi/label/2007/103951s5164lbl.pdf. 
  18. "Information on Erythropoiesis Stimulating Agents (ESA) (marketed as Procrit, Epogen, and Aranesp)". U.S. Food and Drug Administration. 26 January 2009. https://www.fda.gov/cder/drug/infopage/RHE/default.htm. 
  19. "Epoetin alfa Interactions Checker". https://www.drugs.com/drug-interactions/epoetin-alfa.html. 
  20. "Secret ties to industry and conflicting interests in cancer research". American Journal of Industrial Medicine 50 (3): 227–33. March 2007. doi:10.1002/ajim.20357. PMID 17086516.  https://dx.doi.org/10.1002%2Fajim.20357
  21. Maryann Napoli (5 October 2011), Whistleblower's story: New book reviewed, Center for Medical Consumers, http://medicalconsumers.org/2011/10/05/whistleblowers-story-new-book-reviewed/, retrieved 12 February 2012 | archive-url= | archive-date=5 January 2012
  22. "Drug Rep in $3B Procrit Case: "80% of My Sales Were Medicare Fraud"; Carried $400K in "Cash"". CBS news. 17 August 2009. http://www.cbsnews.com/8301-505123_162-42842558/drug-rep-in-3b-procrit-case-80-of-my-sales-were-medicare-fraud-carried-400k-in-cash/. 
  23. "Binocrit EPAR". 17 September 2018. https://www.ema.europa.eu/en/medicines/human/EPAR/binocrit. 
  24. "Epoetin Alfa Hexal EPAR". 17 September 2018. https://www.ema.europa.eu/en/medicines/human/EPAR/epoetin-alfa-hexal. 
  25. "Abseamed EPAR". https://www.ema.europa.eu/en/medicines/human/EPAR/abseamed. 
More
Upload a video for this entry
Information
Subjects: Cell Biology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 1.1K
Entry Collection: HandWiki
Revision: 1 time (View History)
Update Date: 01 Nov 2022
Notice
You are not a member of the advisory board for this topic. If you want to update advisory board member profile, please contact office@encyclopedia.pub.
OK
Confirm
Only members of the Encyclopedia advisory board for this topic are allowed to note entries. Would you like to become an advisory board member of the Encyclopedia?
Yes
No
${ textCharacter }/${ maxCharacter }
Submit
Cancel
There is no comment~
${ textCharacter }/${ maxCharacter }
Submit
Cancel
${ selectedItem.replyTextCharacter }/${ selectedItem.replyMaxCharacter }
Submit
Cancel
Confirm
Are you sure to Delete?
Yes No
Academic Video Service